Abstract 2958: SAR408701: An anti-CEACAM5-maytansinoid antibody-drug conjugate to treat CEACAM5-positive neuroendocrine prostate cancer (NEPC)
Year: 2025
Type: conference-abstract
Source: Cancer Research
Authors: Loic Poiraudeau, Bigot Ludovic, Cedric Pobel, Naoual Menssouri, Marine Aglave, Catline Nobre, Alice Bernard-Tessier, Natacha Naoun, Anna Patrikidou, Claudio Nicotra, Maud Ngocamus, Benjamin Besse, Karim Fizazi, Jean-Yves Scoazec, Anne-Marie Lefebvre, Celine Nicolazzi, Nathalie Mace, Anne-Laure Bauchet, Yohann Loriot
Institutions: Institut Gustave Roussy, Sanofi (France)
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4409689737